LONDON (Reuters) – Apple and Amazon have successfully fought off a mass lawsuit in Britain over alleged collusion between the tech giants to remove resellers of new Apple products from Amazon’s website, a tribunal ruled on Tuesday. The lawsuit was brought by consumer law academic Christine Riefa on behalf of around 36 million British consumers…
By Eduardo Baptista, Katie Paul and Krystal Hu (Reuters) – New users have piled in to Chinese social media app RedNote just days before a proposed U.S. ban on the popular social media app TikTok, as the lesser-known company rushes to capitalize on the sudden influx while walking a delicate line of moderating English-language content,…
(Reuters) – Microsoft is planning to halt hiring in part of its consulting business in the U.S. in a bid to cut costs, CNBC reported on Tuesday, citing an internal memo. The tech giant is looking to manage overall expenses as it looks to continue investments in its artificial intelligence (AI) efforts. Earlier this month,…
By Nupur Anand MIAMI (Reuters) – Wall Street bankers are already upbeat about a revival in mergers and acquisitions this year that will buoy broader investment banking activity. It may take some time for deals to materialize, but buyouts including bank deals could gain momentum in the second half of 2025. Here are quotes from…
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly’s stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time sales have disappointed since the drug’s launch in late 2023. The company’s shares were trading at $739.23, on track for their worst single-day decline…
By Ahmed Aboulenein and Amina Niasse WASHINGTON (Reuters) -The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said on Tuesday. From 2017 to 2022, the companies — UnitedHealth Group’s Optum, CVS Health’s…
By Jarrett Renshaw WASHINGTON (Reuters) -Tech CEOs Elon Musk, Jeff Bezos and Mark Zuckerberg will attend U.S. President-elect Donald Trump’s inauguration on Monday, according to a source familiar with planning for the event. The chief executives of Tesla, Amazon and Meta will be featured prominently at Trump’s swearing in, sitting with the Republican’s Cabinet nominees…
(Reuters) – Generative artificial intelligence bellwether OpenAI said on Tuesday that it is introducing a beta feature called Tasks to ChatGPT, signaling the company’s foray into the virtual assistant space, competing with Apple’s Siri and Amazon’s Alexa. Tasks will enable ChatGPT users to request tasks to be performed at a future time, including one-time reminders…
(Reuters) -Eli Lilly said on Monday it plans to buy Scorpion Therapeutics’ experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of cancer treatments. The company will acquire Scorpion’s experimental oral therapy, STX-478, which is currently being tested in early-stage trials for breast cancer and other advanced solid tumors. The…
(Reuters) – The European Union is considering expanding its investigation into whether Elon Musk’s social media network X breached its content moderation rulebook, Bloomberg News reported on Monday, citing the bloc’s tech policy chief. The EU started investigating X, formerly Twitter, in late 2023 over suspected breaches of obligations, partly relating to posts following Hamas’…
